These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 33841132)

  • 1. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.
    Hofschröer V; Najder K; Rugi M; Bouazzi R; Cozzolino M; Arcangeli A; Panyi G; Schwab A
    Front Pharmacol; 2020; 11():586599. PubMed ID: 33841132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion channels in control of pancreatic stellate cell migration.
    Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
    Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma.
    Schnipper J; Dhennin-Duthille I; Ahidouch A; Ouadid-Ahidouch H
    Front Pharmacol; 2020; 11():568993. PubMed ID: 33178018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TRPC1 channels in pressure-mediated activation of murine pancreatic stellate cells.
    Fels B; Nielsen N; Schwab A
    Eur Biophys J; 2016 Oct; 45(7):657-670. PubMed ID: 27670661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
    Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
    Front Oncol; 2020; 10():621937. PubMed ID: 33520728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.
    Tarannum M; Vivero-Escoto JL
    Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
    Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
    Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.
    Huang HC; Sung YC; Li CP; Wan D; Chao PH; Tseng YT; Liao BW; Cheng HT; Hsu FF; Huang CC; Chen YT; Liao YH; Hsieh HT; Shih YC; Liu IJ; Wu HC; Lu TT; Wang J; Chen Y
    Gut; 2022 Sep; 71(9):1843-1855. PubMed ID: 34921062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting the balance between tumor epithelia and stroma is a possible therapeutic approach for pancreatic cancer.
    Wang Z; Li J; Chen X; Duan W; Ma Q; Li X
    Med Sci Monit; 2014 Oct; 20():2002-6. PubMed ID: 25327552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.
    Cannon A; Thompson C; Hall BR; Jain M; Kumar S; Batra SK
    Genes Cancer; 2018 Mar; 9(3-4):78-86. PubMed ID: 30108679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
    Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
    PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmoplasia of pancreatic ductal adenocarcinoma.
    Pandol S; Edderkaoui M; Gukovsky I; Lugea A; Gukovskaya A
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S44-7. PubMed ID: 19896098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the mechanical stiffness of pancreatic ductal adenocarcinoma.
    Kpeglo D; Hughes MDG; Dougan L; Haddrick M; Knowles MA; Evans SD; Peyman SA
    Matrix Biol Plus; 2022 Jun; 14():100109. PubMed ID: 35399702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment.
    Wu TC; Liao CY; Lu WC; Chang CR; Tsai FY; Jiang SS; Chen TH; Lin KM; Chen LT; Chang WW
    J Exp Clin Cancer Res; 2022 Apr; 41(1):137. PubMed ID: 35410237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
    Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.